4-Chromenonyl-1,4-dihydropyridinecarbonitriles and the use thereof

US8058447B2 · kind B2 · utility

Assignee

• Bayer Pharma Aktiengesellschaft · DE

Inventors

• Alexander Kuhl · Hagen, DE
• Peter Kolkhof · Wuppertal, DE
• Heike Heckroth · Odenthal, DE
• Karl-Heinz Schlemmer · Wuppertal, DE
• Ingo Flamme · Bergneustadt, DE
• Santiago Figueroa Perez · Leverkusen, DE
• Heike Gielen-Haertwig · Monheim, DE
• Rolf Grosser · Schwandorf, DE
• Jens-Kerim Ergüden · Uerdingen, DE
• Dieter Lang · Velbert, DE

Key dates

• Filing date: Jul 14, 2006
• Grant date: Nov 15, 2011
• Expiry date: Sep 1, 2027

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present application relates to novel 4-chromenonyl-1,4-dihydropyridinecarbonitriles, processes for their preparation, pharmaceutical compositions containing them, and their use for the treatment and/or prophylaxis of diseases, especially cardiovascular disorders.